官宣:新增3所医药类公办本科院校和41个备案审批药学相关本科专业

2021-04-03 医谷网 医谷网

近期,为提升专业人才培养、优化专业设置和教学标准,多地开展院校合并转设工作。

近期,为提升专业人才培养、优化专业设置和教学标准,多地开展院校合并转设工作。

3月18日,江苏省教育厅官网公示五所独立学院合并转设的相关事宜,其中包括:将南京中医药大学翰林学院与江苏医药职业学院合并转设为省属公办本科学校,向社会公示。公示时间为2021年3月18日至2021年3月24日。

据了解,早在1月31日,盐城市便与南京中医药大学签订了全面战略合作协议。根据合作协议,盐城市将依托南京中医药大学在中医药教育、科研、医疗等领域的学科、人才、科技优势,积极打造具有集聚效应的中医药大健康产业集群,着力创建服务区域医疗卫生事业发展的医学本科院校,推动该市卫生健康事业加快发展,努力让盐城人民在家门口享受一流的医疗服务。

2月23日,浙江省教育厅发布《关于浙江海洋大学东海科学技术学院提出申报独立学院转设基本情况的公示》。根据公示,浙江海洋大学东海科学技术学院将与浙江医药高等专科学校合并,成立浙江药学院(暂定名)。

公示中披露的“独立学院提出转设申报基本情况表”显示,浙江药学院(暂名)将以浙江海洋大学东海科学技术学院、浙江医药高等专业学校为建校基础,学校占地面积933亩,校舍面积达30.79万平方米,教学科研仪器设备总值1.6亿元,图书105万册,专任教师总数为589人,其中浙江医药高等专科学校498人,东科学院91人,正高职称51人,副高职称160人。

江西

3月15日,江西省人民政府办公厅网站发布了《关于同意设立南昌医学院的批复》。同意设立南昌医学院,办学规模暂定10000人。同时撤销江西中医药大学科技学院建制。

江西中医药大学科技学院这所成立于2001年的独立学院,自此转为公办本科学校,将由江西省政府主办、省卫健委行政主管、省教育厅业务指导。新设立的南昌医学院定位于应用型高等学校,主要培养区域经济社会发展所需要的高素质应用型、技术技能型人才。

近期,国家教育部官宣了《关于公布2020年度普通高等学校本科专业备案和审批结果的通知》(教高函〔2021〕1号),对普通高等学校本科专业目录进行更新。

据统计,2020年度各高校新增药学相关备案本科专业35个,新增药学相关审批本科专业3个,药学相关调整学位授予门类或修业年限专业3个

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1775070, encodeId=08e51e7507045, content=<a href='/topic/show?id=5e9a6094488' target=_blank style='color:#2F92EE;'>#本科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60944, encryptionId=5e9a6094488, topicName=本科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df2b38746341, createdName=wushaoling, createdTime=Sun Sep 12 12:46:54 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022718, encodeId=b9922022e187d, content=<a href='/topic/show?id=81cf353e0b0' target=_blank style='color:#2F92EE;'>#医药类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35370, encryptionId=81cf353e0b0, topicName=医药类)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Mon Aug 02 07:46:54 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410125, encodeId=10a4141012538, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 13:46:54 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590985, encodeId=6a95159098566, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Mon Apr 05 13:46:54 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
    2021-09-12 wushaoling
  2. [GetPortalCommentsPageByObjectIdResponse(id=1775070, encodeId=08e51e7507045, content=<a href='/topic/show?id=5e9a6094488' target=_blank style='color:#2F92EE;'>#本科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60944, encryptionId=5e9a6094488, topicName=本科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df2b38746341, createdName=wushaoling, createdTime=Sun Sep 12 12:46:54 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022718, encodeId=b9922022e187d, content=<a href='/topic/show?id=81cf353e0b0' target=_blank style='color:#2F92EE;'>#医药类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35370, encryptionId=81cf353e0b0, topicName=医药类)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Mon Aug 02 07:46:54 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410125, encodeId=10a4141012538, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 13:46:54 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590985, encodeId=6a95159098566, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Mon Apr 05 13:46:54 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1775070, encodeId=08e51e7507045, content=<a href='/topic/show?id=5e9a6094488' target=_blank style='color:#2F92EE;'>#本科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60944, encryptionId=5e9a6094488, topicName=本科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df2b38746341, createdName=wushaoling, createdTime=Sun Sep 12 12:46:54 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022718, encodeId=b9922022e187d, content=<a href='/topic/show?id=81cf353e0b0' target=_blank style='color:#2F92EE;'>#医药类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35370, encryptionId=81cf353e0b0, topicName=医药类)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Mon Aug 02 07:46:54 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410125, encodeId=10a4141012538, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 13:46:54 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590985, encodeId=6a95159098566, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Mon Apr 05 13:46:54 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
    2021-04-05 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1775070, encodeId=08e51e7507045, content=<a href='/topic/show?id=5e9a6094488' target=_blank style='color:#2F92EE;'>#本科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60944, encryptionId=5e9a6094488, topicName=本科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df2b38746341, createdName=wushaoling, createdTime=Sun Sep 12 12:46:54 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022718, encodeId=b9922022e187d, content=<a href='/topic/show?id=81cf353e0b0' target=_blank style='color:#2F92EE;'>#医药类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35370, encryptionId=81cf353e0b0, topicName=医药类)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Mon Aug 02 07:46:54 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410125, encodeId=10a4141012538, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Apr 05 13:46:54 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590985, encodeId=6a95159098566, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Mon Apr 05 13:46:54 CST 2021, time=2021-04-05, status=1, ipAttribution=)]
    2021-04-05 cenghis